The FDA has granted de novo classification to an AI software module that puts a second pair of eyes on colonoscopy videos in real time and is compatible with any endoscope.

Artificially intelligent personal digital assistants controlled by voice à la Amazon Echo and Google Home have a bright future in healthcare. However, they will only go so far as a transformative technology. 

The European Union has granted CE mark approval to a breast cancer screening system that combines a thermal imaging device with cloud-hosted AI analytics.

An established company in the spinal device market has added a 3D-printed vertebral spacer to its line of FDA-cleared products.

Apart from software, the technique needs nothing more than a halogen lamp and a commercial-grade spectrometer. This pairing can be had together for well under $5,000.

The FDA has given the all-clear to AI software that measures nodules in the lungs, a tedious but important task for radiologists monitoring changes in these growths over time.

An AI system for diagnosing prostate cancer on biopsy slides has achieved 98%-plus performance in sensitivity, positive predictive value, specificity and negative predictive value.

Two healthcare heavyweights are combining forces to form a technology center they hope will, over the next 10 years, “fundamentally advance the pace” of discovery in medical science and healthcare innovation.